Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results

Rhea-AI Summary

Legend Biotech (NASDAQ: LEGN), a global cell therapy leader, has scheduled an investor conference call to discuss its first quarter 2025 financial results. The call will take place on Tuesday, May 13, 2025, at 8:00 am ET.

Key Details:

• Senior leadership will present the company's Q1 2025 performance
• Investors can access the live audio webcast through a provided weblink
• A replay of the webcast and earnings release will be available
• Post-call materials will be accessible through Legend Biotech's Investor Relations website under Events and Presentations

The materials will be made available approximately two hours after the call concludes.

SOMERSET, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, May 13, 2025, to review first-quarter 2025 results.

During the webcast and conference call, senior leaders will provide an overview of Legend Biotech’s performance for the quarter.

Investors and other interested parties may join the live audio webcast of the call via this weblink.

A replay of the webcast and earnings news release will be available through the Investor Relations section of Legend Biotech’s website under the Events and Presentations section approximately two hours after the call concludes.

ABOUT LEGEND BIOTECH

With over 2,500 employees, Legend Biotech is the largest standalone cell therapy company and a pioneer in treatments that change cancer care forever. The company is at the forefront of the CAR-T cell therapy revolution with CARVYKTI^®, a one-time treatment for relapsed or refractory multiple myeloma, which it develops and markets with collaborator Johnson & Johnson. Centered in the US, Legend is building an end-to-end cell therapy company by expanding its leadership to maximize CARVYKTI’s patient access and therapeutic potential. From this platform, the company plans to drive future innovation across its pipeline of cutting-edge cell therapy modalities.

Learn more at www.legendbiotech.com, and follow us on X (formerly Twitter) and LinkedIn.

INVESTOR CONTACT:

Jessie Yeung
Tel: (732) 956-8271
jessie.yeung@legendbiotech.com

PRESS CONTACT:

Mary Ann Ondish
Tel: (914) 552-4625
media@legendbiotech.com

FAQ

When is Legend Biotech (LEGN) releasing Q1 2025 earnings?

Legend Biotech (LEGN) will release its Q1 2025 earnings on Tuesday, May 13, 2025, with a conference call scheduled for 8:00 am ET.

How can investors join Legend Biotech's Q1 2025 earnings call?

Investors can join Legend Biotech's Q1 2025 earnings call through a live audio webcast available via the provided weblink. The call is scheduled for May 13, 2025, at 8:00 am ET.

Where can I find Legend Biotech's Q1 2025 earnings replay?

The earnings call replay and news release will be available on Legend Biotech's website under the Events and Presentations section of Investor Relations, approximately two hours after the call ends.

What will be discussed in Legend Biotech's Q1 2025 earnings call?

Senior leaders will provide an overview of Legend Biotech's performance for the first quarter of 2025 during the earnings call.

What time is Legend Biotech's Q1 2025 investor conference call?

Legend Biotech's Q1 2025 investor conference call is scheduled for 8:00 am ET on Tuesday, May 13, 2025.